Skip directly to content

Partnering Overview

Selventa is leveraging a unique infrastructure to develop novel SysDx based solutions.

The ideal strategic partner for ClarifyRA and ClarifyIBD is one that provides:

  • Access to patient samples and physicians
  • CLIA lab (ideally with access to molecular profiling capabilities)
  • Regulatory and reimbursement experience
  • Capabilities for full commercialization

The ideal pharmaceutical partner for Companion Diagnostic development is one who is interested in:

  • Holistic approach for biomarker discovery using patient data
  • Differentiation
  • Extract premium pricing (e.g. Treatments that achieve 90% in a stratified patient group versus 50% in an unstratified general patient population)
  • Actionable insight into different molecular disease-drivers
Please contact us at corpdev@selventa.com.